(HealthDay)—Researchers may have uncovered a key reason some people remain sharp as a tack into their 80s and 90s: Their brains resist the buildup of certain proteins that mark Alzheimer's disease.
Feb 23, 2021
0
14
Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons ...
Feb 19, 2021
0
17
A new Northwestern Medicine study showed cognitive SuperAgers have resistance to the development of fibrous tangles in a brain region related to memory and which are known to be markers of Alzheimer's disease.
Feb 17, 2021
0
19
As people age, a normal brain protein known as amyloid beta often starts to collect into harmful amyloid plaques in the brain. Such plaques can be the first step on the path to Alzheimer's dementia. When they form around ...
Feb 17, 2021
1
237
A team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State University and D. Mendeleev University of Chemical Technology of Russia has summarized metal-containing diagnostic agents for positron ...
Feb 9, 2021
0
0
Amyloid-beta and tau are the two key abnormal protein deposits that accumulate in the brain during the development of Alzheimer's disease, and detecting their buildup at an early stage may allow clinicians to intervene before ...
Feb 2, 2021
0
2
A new study published in the Journal of Alzheimer's Disease carried out by researchers at the Marqués de Valdecilla-IDIVAL University Hospital, in collaboration with researchers at the University of Bonn Medical Center, ...
Jan 21, 2021
0
13
More than 5.7 million Americans live with Alzheimer's disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure.
Jan 21, 2021
0
5
The older we grow, the weaker our muscles get, riddling old age with frailty and physical disability. But this doesn't only affect the individual, it also creates a significant burden on public healthcare. And yet, research ...
Jan 19, 2021
0
425
A team of scientists at UCL have found that blood tests measuring the hallmark Alzheimer's protein, b-amyloid (amyloid), could radically reduce the cost of clinical trials and potentially open the door to treating the disease ...
Jan 19, 2021
0
11
